iSpecimen, Inc. (ISPC)
1.08
-0.06
(-5.26%)
USD |
NASDAQ |
Oct 02, 16:00
1.05
-0.03
(-2.78%)
After-Hours: 20:00
iSpecimen Gross Profit Margin (Quarterly) : -87.43% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -87.43% |
| March 31, 2026 | -41.22% |
| December 31, 2025 | -1.75K% |
| September 30, 2025 | -521.3% |
| June 30, 2025 | -22.97% |
| March 31, 2025 | -3.07% |
| December 31, 2024 | -23.64% |
| September 30, 2024 | 21.23% |
| June 30, 2024 | 29.07% |
| March 31, 2024 | 30.28% |
| December 31, 2023 | 23.71% |
| September 30, 2023 | 31.23% |
| June 30, 2023 | 14.33% |
| March 31, 2023 | 45.13% |
| Date | Value |
|---|---|
| December 31, 2022 | 52.41% |
| September 30, 2022 | 54.26% |
| June 30, 2022 | 57.25% |
| March 31, 2022 | 53.71% |
| December 31, 2021 | 52.05% |
| September 30, 2021 | 66.39% |
| June 30, 2021 | 48.72% |
| March 31, 2021 | 45.22% |
| December 31, 2020 | 42.85% |
| September 30, 2020 | 59.83% |
| June 30, 2020 | 68.50% |
| March 31, 2020 | 61.77% |
| December 31, 2019 | 51.88% |
| September 30, 2019 | 29.74% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| LataMed AI Corp. | -- |
| SCWorx Corp. | 26.95% |
| Health Catalyst, Inc. | 34.67% |
| GoodRx Holdings, Inc. | 78.41% |
| Claritev Corp. | 30.72% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -611.8% |
| Return on Assets | -148.1% |
| Return on Invested Capital | -535.3% |
| Profit Margin (Quarterly) | -897.2% |
| Operating Margin (Quarterly) | -897.3% |
| Return on Net Operating Assets | -251.3% |